The KETO-CTA (#LMHRstudy) vs Matched Control (#MiHeart) analysis is now published in Metabolism.
https://doi.org/10.1016/j.metabol.2024.155854
METHODS
80 Participants of #LMHRstudy fell within #MiHeart age range and were then matched 1:1 for age, gender, race, diabetes mellitus, hyperlipidemia, hypertension, and past smoking to asymptomatic subjects from the #MiHeart cohort.
PRIMARY ANALYSIS
High resolution heart scans (#CCTA) allowing for primary analysis of Total Plaque Score (TPS), Total Stenosis Score (TSS) and Segment Involvement Score (SIS)
RESULTS
The matched mean age was 55.5 years, with mean #LDL cholesterol of 272 mg/dL (max LDL-C 591) mg/dl and mean 4.7 years duration on a ketogenic diet.
- There was no significant difference in coronary plaque burden of #LMHRstudy (mean LDL-C 272) cohort as compared to #MiHeart controls (mean LDL 123 mg/dl); nb: pre-KETO LDL-C in KETO group was 122 mg/dl
- There was no significant difference in CAC (median and IQR) [0 (0,56)] versus [1 (0, 49)], p = 0.520
- No relationship of LDL-C elevations and plaque
Note 1 – This analysis is on baseline scans, we will have further data on the Keto-CTA longitudinal analysis in the coming months. And — as always — please continue to work with your doctor.
Note 2 – this is a published abstract, but is not open access. A full paper for this match analysis will be published soon in a different journal and will be completely open access.
Thanks for sharing!! 🙂
Any data on eGFR in athletes who are LMHR?
When muscle mass is higher than average and consequent eGFR is low, can we somehow determine if renal function is truly impaired?